Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 12, 2006, Pages 2427-2434

  Agudo, Antonio ^a   Sala, Núria ^b   Pera, Guillem ^a   Capellá, Gabriel ^a   Berenguer, Antonio ^a   García, Nadia ^a,b   Palli, Domenico ^c   Boeing, Heiner ^d   Del Giudice, Giuseppe ^e   Saieva, Calogero ^c   Carneiro, Fatima ^f   Berrino, Franco ^g   Sacerdote, Carlotta ^h   Tumino, Rosario ⁱ   Panico, Salvatore ^j   Berglund, Göran ^k   Simán, Henrik ^k   Stenling, Roger ^l   Hallmans, Göran ^l   Martínez, Carmen ^m   Bilbao, Roberto ⁿ   Barricarte, Aurelio ^o   Navarro, Carmen ^p   Quirós, José R ^q   Allen, Naomi ^r   Key, Tim ^r   Bingham, Sheila ^s   Khaw, Kay Tee ^s   Linseisen, Jakob ^t   Nagel, Gabriele ^t   Overvad, Kim ^u,v   Tjonneland, Anne ^w   Olsen, Anja ^w   Bueno De Mesquita, H Bas ^x   Boshuizen, Hendriek C ^x   Peeters, Petra H ^y   Numans, Mattijs E ^y   Clavel Chapelon, Françoise ^z   Boutron Ruault, Marie Christine ^z   Trichopoulou, Antonia ^aa   Lund, Eiliv ^ab   Offerhaus, Johan ^ac   Jenab, Mazda ^ad   Ferrari, Pietro ^ad   Norat, Teresa ^ad   Riboli, Elio ^ae   González, Carlos A ^a   more..

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b Institut de Recerca Oncologica   (Spain)

^c CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^d GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^e CHIRON VACCINES   (Italy)

^f University of Porto   (Portugal)

^g NATIONAL CANCER INSTITUTE   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ CIVILE M P AREZZO HOSPITAL   (Italy)

^j UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^k LUND UNIVERSITY   (Sweden)

^l UMEÅ UNIVERSITY   (Sweden)

^m ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

ⁿ Fundación Vasca de Innovación e Investigación Sanitarias   (Spain)

^o INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^p Instituto Murciano de Investigación Biosanitaria Arrixaca   (Spain)

^q Direccion General de Salud Publica   (Spain)

^r UNIVERSITY OF OXFORD   (United Kingdom)

^s MEDICAL RESEARCH COUNCIL   (United Kingdom)

^t Division of Clinical Epidemiology   (Germany)

^u AALBORG UNIVERSITY HOSPITAL   (Denmark)

^v AARHUS UNIVERSITY   (Denmark)

^w INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^x NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^y UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^z INSERM   (France)

^aa UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^ab UNIVERSITY OF TROMSØ   (Norway)

^ac ACADEMIC MEDICAL CENTER   (Netherlands)

^ad INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ae IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; EPOXIDE HYDROLASE; EPOXIDE HYDROLASE 1; GLUTATHIONE TRANSFERASE T1; HISTIDINE; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; EUROPE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NUTRITION; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; CARCINOGENS; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; EUROPE; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL SCIENCES; POLYCYCLIC HYDROCARBONS, AROMATIC; POLYMORPHISM, GENETIC; SMOKING; STOMACH NEOPLASMS; TOBACCO;

EID: 33846007251     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0072     Document Type: Article

References (43)

1. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 83. Tobacco smoke and involuntary smoking. Lyon (France): International Agency for Research on Cancer; 2004.
2. Hecht SS. Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-44.
3. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000;9:3-28.
4. Gonzalez CA, Fera G, Agudo A, et al. Smoking and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2003;107:629-34.
5. Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P, editors. Metabolic polymorphisms and susceptibility to cancer. Lyon (France): IARC Scientific Publications; 1999.
6. Gonzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002;100:249-60.
7. Agudo A, Sala N, Fera G, et al. No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2006;15:1043-5.
8. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
9. Harth V, Bruning T, Abel J, et al. Real-time genotyping of cytochrome P4501A1 A4889G and T6235C polymorphisms. Mol Cell Probes 2001;15:93-7.
10. Voso MT, D'Alo F, Putzulu R, et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood 2002;100:2703-7.
11. Garte S, Boffetta P, Caporaso N, et al. Metabolic gene allele nomenclature. Cancer Epidemiol Biomarkers Prev 2001;10:1305-6.
12. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995;29:311-22.
13. Breslow NE, Day NE. Statistical methods in cancer research. Vol. I-the analysis of case-control studies. IARC Scientific Publications, No. 32. Lyon (France): International Agency for Research on Cancer; 1980.
14. Gonzalez CA, Jakszyn P, Fera G, et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:345-54.
15. Gonzalez CA, Fera G, Agudo A, et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer 2006;118:2559-66.
16. Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 2004;33:30-42.
17. Nan HM, Park JW, Song YJ, et al. Kimchi and soybean pastes are risk factors of gastric cancer. World J Gastroenterol 2005;11:3175-81.
18. Suzuki S, Muroishi Y, Nakanishi I, Oda Y. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer. J Gastroenterol 2004;39:220-30.
19. Sachse C, Bhambra U, Smith G, et al. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium, and influence on caffeine metabolism. Br J Clin Pharmacol 2003;55:68-76.
20. Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D, Silva AE. GSTT1, GSTM1, and CYP2E1 genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population. World J Gastroenterol 2004;10:1240-5.
21. Deakin M, Elder J, Hendrickse C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric, and colorectal cancers. Carcinogenesis 1996;17:881-4.
22. Tamer L, Ates NA, Ates C, et al. Glutathione S-transferase M1, T1, and P1 genetic polymorphisms, cigarette smoking, and gastric cancer risk. Cell Biochem Funct 2005;23:267-72.
23. Torres MM, Acosta CP, Sicard DM, Groot R. Genetic susceptibility and risk of gastric cancer in a human population of Cauca, Colombia [in Spanish]. Biomedica 2004;24:153-62.
24. Gao CM, Takezaki T, Wu JZ, et al. Glutathione-S-transferases M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea, and risk of esophageal and stomach cancers: a case-control study of a high-incidence area in Jiangsu Province, China. Cancer Lett 2002;188:95-102.
25. Saadat I, Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett 2001;169:21-6.
26. Choi SC, Yun KJ, Kim TH, et al. Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression. Cancer Lett 2003;195:169-75.
27. Katoh T, Nagata N, Kuroda Y, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 1996;17:1855-9.
28. Lan Q, Chow WH, Lissowska J, et al. Glutathione S-transferase genotypes and stomach cancer in a population-based case-control study in Warsaw, Poland. Pharmacogenetics 2001;11:655-61.
29. Setiawan VW, Zhang ZF, Yu GP, et al. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev 2000;9:73-80.
30. Palli D, Saieva C, Gemma S, et al. GSTT1 and GSTM1 gene polymorphisms and gastric cancer in a high-risk Italian population. Int J Cancer 2005;115:284-9.
31. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88.
32. Omiecinski CJ, Hassett C, Hosagrahara V. Epoxide hydrolase-polymorphism and role in toxicology. Toxicol Lett 2000;112-3:365-70.
33. Shimada T, Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci 2004;95:1-6.
34. Smith WA, Gupta RC. Determining efficacy of cancer chemopreventive agents using a cell-free system concomitant with DNA adduction. Mutat Res 1999;425:143-52.
35. Gsur A, Zidek T, Schnattinger K, et al. Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br J Cancer 2003;89:702-6.
36. Jourenkova-Mironova N, Mitrunen K, Bouchardy C, Dayer P, Benhamou S, Hirvonen A. High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res 2000;60:534-6.
37. Wang LD, Zheng S, Liu B, Zhou JX, Li YJ, Li JX. CYP1A1, GSTs, and mEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high-incidence area in north China. World J Gastroenterol 2003;9:1394-7.
38. Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hankinson SE, Hunter DJ. Epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study. Carcinogenesis 2004;25:1211-8.
39. Palli D, Russo A, Ottini L, et al. Red meat, family history, and increased risk of gastric cancer with microsatellite instability. Cancer Res 2001;61:5415-9.
40. Starzynska T, Ferenc K, Wex T, et al. The association between the interleukin-1 polymorphisms and gastric cancer risk depends on the family history of gastric carcinoma in the study population. Am J Gastroenterol 2006;101:248-54.
41. Wacholder S, Rothman N, Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 2000;92:1151-8.
42. Schaid DJ, Jacobsen SJ. Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am J Epidemiol 1999;149:706-11.
43. Garcia-Closas M, Lubin JH. Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. Am J Epidemiol 1999;149:689-92.